How amyloid precursor protein protects itself from cleavage.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

2 citing papers in PubMed.

1. Mutations of beta-amyloid precursor protein alter the consequence of Alzheimer's disease pathogenesis.Neural regeneration research · 2019
   Article
2. Ginsenoside Rb1 improves learning and memory ability through its anti-inflammatory effect in AβAmerican journal of translational research · 2019
   Article

Corrections and comments

• Comment on
  Conformational changes induced by the A21G Flemish mutation in the amyloid precursor protein lead to increased Aβ production.2014

Authors and funding

2 authors.

Funding

Abstract

Indexed as